Mr. Esposito spends a lot of his time being the CEO of Armune, a private company headquartered in Michigan. The company has been successful developing a new diagnostic test for prostate cancer but, recently, sold off some of the testing rights to another company. Small private companies, just like small public companies, are in constant need of cash and spend a lot of their time trying to raise said cash. How much effort is the BOD of Medizone putting into the promotion of the company and its lead product? I am talking about real, calculated global business plans and not some fly-by-night scheme that falls in and out of one's lap. I repeat that it looks like our two newest board members do not have the time to tend to Medizone, and it looks like we have a third one in Indiana unengaged. The two remaining board members do not have marketing backgrounds. One is a scientist with credentials who invented the lead product, and the other one is a long term keeper of the gate with no defined networking/marketing skills for this industry. If all of us knew absolutely nothing about Medizone and/or its personnel and looked at the above information, what probability of success would we place on it? The perks these people are drawing continue to dilute our holdings. What justifies this level of pay when we aren't seeing the work or the communication proving the existence of the work?
